Registry Experience at the Washington Hospital Center With Drug Eluting Stents - Synergy

NCT ID: NCT02823730 Phase: Status: COMPLETED Enrollment: 500 Completion: 2023-05

Conditions

Incidence of Major Adverse Cardiac Events

Interventions

PCI with Synergy Stent

Summary

To compare the incidence of major adverse cardiac events among a series of patients receiving the Synergy drug-eluting stent with bioabsorbable polymer to historical controls who have received the Promus Premier drug-eluting stent with durable polymer.

Primary Outcome

Major adverse cardiac events (MACE)

Source

ClinicalTrials.gov